Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000203025 | SCV000257999 | uncertain significance | not specified | 2015-07-17 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000203025 | SCV000593248 | likely benign | not specified | 2015-11-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000559361 | SCV000649250 | likely benign | Hereditary spastic paraplegia 50 | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847910 | SCV002105883 | uncertain significance | Hereditary spastic paraplegia | 2022-01-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002292486 | SCV002586180 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | AP4M1: BP4, BP7 |
Prevention |
RCV003927869 | SCV004739520 | likely benign | AP4M1-related disorder | 2021-02-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |